ARCHIVES

NCI To End CIS Partnership Program In 2010.

This article is from The Cancer Letter archive.

Vol. 34 No. 44 | December 5, 2008

Download PDF Visit The Full Archive

Related Articles

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

DCPC Forms Decision Network To oversee Chemoprevention

July 16, 1993

Cancer Control Progress, Challenge Mark ACS Observance

October 18, 1991

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985